Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Addendum
Announcement
Announcements
Author’ response
Author’s reply
Authors' response
Authors#x2019; response
Book Received
Book Review
Book Reviews
Books Received
Centenary Review Article
Clinical Image
Clinical Images
Commentary
Communicable Diseases - Original Articles
Correspondence
Correspondence, Letter to Editor
Correspondences
Correspondences & Authors’ Responses
Corrigendum
Corrrespondence
Critique
Current Issue
Editorial
Editorial Podcast
Errata
Erratum
FORM IV
GUIDELINES
Health Technology Innovation
IAA CONSENSUS DOCUMENT
Innovations
Letter to Editor
Malnutrition & Other Health Issues - Original Articles
Media & News
Notice of Retraction
Obituary
Original Article
Original Articles
Panel of Reviewers (2006)
Panel of Reviewers (2007)
Panel of Reviewers (2009) Guidelines for Contributors
Perspective
Policy
Policy Document
Policy Guidelines
Policy, Review Article
Policy: Correspondence
Policy: Editorial
Policy: Mapping Review
Policy: Original Article
Policy: Perspective
Policy: Process Paper
Policy: Scoping Review
Policy: Special Report
Policy: Systematic Review
Policy: Viewpoint
Practice
Practice: Authors’ response
Practice: Book Review
Practice: Clinical Image
Practice: Commentary
Practice: Correspondence
Practice: Letter to Editor
Practice: Method
Practice: Obituary
Practice: Original Article
Practice: Pages From History of Medicine
Practice: Perspective
Practice: Review Article
Practice: Short Note
Practice: Short Paper
Practice: Special Report
Practice: Student IJMR
Practice: Systematic Review
Pratice, Original Article
Pratice, Review Article
Pratice, Short Paper
Programme
Programme, Correspondence, Letter to Editor
Programme: Authors’ response
Programme: Commentary
Programme: Correspondence
Programme: Editorial
Programme: Original Article
Programme: Originial Article
Programme: Perspective
Programme: Rapid Review
Programme: Review Article
Programme: Short Paper
Programme: Special Report
Programme: Status Paper
Programme: Systematic Review
Programme: Viewpoint
Protocol
Public Notice
Research Brief
Research Correspondence
Retraction
Review Article
Reviewers
Short Paper
Some Forthcoming Scientific Events
Special Opinion Paper
Special Report
Special Section Nutrition & Food Security
Status Paper
Status Report
Strategy
Student IJMR
Systematic Article
Systematic Review
Systematic Review & Meta-Analysis
View Point
Viewpoint
White Paper
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Addendum
Announcement
Announcements
Author’ response
Author’s reply
Authors' response
Authors#x2019; response
Book Received
Book Review
Book Reviews
Books Received
Centenary Review Article
Clinical Image
Clinical Images
Commentary
Communicable Diseases - Original Articles
Correspondence
Correspondence, Letter to Editor
Correspondences
Correspondences & Authors’ Responses
Corrigendum
Corrrespondence
Critique
Current Issue
Editorial
Editorial Podcast
Errata
Erratum
FORM IV
GUIDELINES
Health Technology Innovation
IAA CONSENSUS DOCUMENT
Innovations
Letter to Editor
Malnutrition & Other Health Issues - Original Articles
Media & News
Notice of Retraction
Obituary
Original Article
Original Articles
Panel of Reviewers (2006)
Panel of Reviewers (2007)
Panel of Reviewers (2009) Guidelines for Contributors
Perspective
Policy
Policy Document
Policy Guidelines
Policy, Review Article
Policy: Correspondence
Policy: Editorial
Policy: Mapping Review
Policy: Original Article
Policy: Perspective
Policy: Process Paper
Policy: Scoping Review
Policy: Special Report
Policy: Systematic Review
Policy: Viewpoint
Practice
Practice: Authors’ response
Practice: Book Review
Practice: Clinical Image
Practice: Commentary
Practice: Correspondence
Practice: Letter to Editor
Practice: Method
Practice: Obituary
Practice: Original Article
Practice: Pages From History of Medicine
Practice: Perspective
Practice: Review Article
Practice: Short Note
Practice: Short Paper
Practice: Special Report
Practice: Student IJMR
Practice: Systematic Review
Pratice, Original Article
Pratice, Review Article
Pratice, Short Paper
Programme
Programme, Correspondence, Letter to Editor
Programme: Authors’ response
Programme: Commentary
Programme: Correspondence
Programme: Editorial
Programme: Original Article
Programme: Originial Article
Programme: Perspective
Programme: Rapid Review
Programme: Review Article
Programme: Short Paper
Programme: Special Report
Programme: Status Paper
Programme: Systematic Review
Programme: Viewpoint
Protocol
Public Notice
Research Brief
Research Correspondence
Retraction
Review Article
Reviewers
Short Paper
Some Forthcoming Scientific Events
Special Opinion Paper
Special Report
Special Section Nutrition & Food Security
Status Paper
Status Report
Strategy
Student IJMR
Systematic Article
Systematic Review
Systematic Review & Meta-Analysis
View Point
Viewpoint
White Paper
View/Download PDF

Translate this page into:

Original Article
161 (
6
); 710-717
doi:
10.25259/IJMR_1779_2024

Prevalence of peripheral neuropathy in type 2 diabetic adults in central Kerala: A cross-sectional study

Department of Community Medicine, Government Medical College, Kottayam, Kerala, India
Department of General Medicine, Government Medical College, Kottayam, Kerala, India
Department of Community Medicine, Government Medical College, Thrissur, Kerala, India
Department of Community Medicine, Government Medical College, Alappuzha, Kerala, India

Present address: #Department of Community Medicine, Government Medical College, Thiruvananthapuram, Kerala, India

Department of Community Medicine, Government Medical College Kannur, Pariyaram, Kerala, India

For correspondence: Dr Ashish T., Department of General Medicine, Government Medical College, Kottayam, Kottayam 686 008, Kerala, India e-mail: ashisht86@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Abstract

Background & objectives

Diabetic peripheral neuropathy (DPN) is one of the most prevalent chronic complications of diabetes mellitus. It is usually insidious in onset, sometimes asymptomatic, predisposing to foot ulcers, muscle and joint diseases. This results in severe disability and impaired quality of life. Hence, this study undertook to estimate the prevalence of DPN among diabetic individuals aged 30 yr and above in Ettumanoor municipality and to explore association with selected factors.

Methods

A semi-structured interview and examination was conducted among 526 diabetic individuals aged 30 yr and above through cluster sampling. DPN was assessed using the Michigan Neuropathic Screening Instrument (MNSI). Data was coded and entered in MS Excel and analysed using IBM SPSS software version 20.

Results

Mean age of study participants was 62.72 +/-9.01 yr with a median duration of diabetes of seven years, with an IQR of 10 yr. Prevalence of DPN as per the MNSI Examination tool was found to be 34.2 per cent [95% confidence interval (C.I.): 30.2-38.4]. In binary logistic regression, factors found to be independent predictors of DPN were age above 60 yr, education below high school education, unemployed status, height >160 cm, insulin use, and presence of nephropathy.

Interpretation & conclusions

Prevalence of DPN among the study population was found to be 34.2 per cent. It was found to be associated with various sociodemographic factors, treatment-related factors, other co-morbidities, and microvascular complications. Overall, it is suggested based on the findings that community-based initiatives are necessary for the timely screening, diagnosis, and treatment of DPN.

Keywords

Diabetes mellitus
diabetic peripheral neuropathy
MNSI
prevalence

Non-communicable disease (NCD) burden has increased globally over the last decade. Diabetes is one of the highly prevalent NCDs in India, and complications from diabetes are the leading causes of morbidity and mortality, which can go undiagnosed for years. Kerala forms the diabetic capital of India with a prevalence as high as 23.6 per cent, double the national average1. Persistently elevated blood sugar levels adversely affect the nerves and blood vessels and can lead to serious complications like diabetic neuropathy. Of all the complications of diabetes, those that occur in the foot are considered preventable2. Only a fifth of diabetic patients are treated for DPN and adequately controlled3. The prevalence of DPN in India ranges from 9.6 to 78 per cent in different studies in different populations4. The factors associated with DPN known from other studies include advancing age, longer duration of diabetes, metabolic factors like poor glycaemic control, dyslipidaemia, obesity, hypertension, habits like smoking, alcohol consumption, lifestyle factors, and presence of other diabetes related complications4-7. As Kerala witnesses an increasing prevalence of diabetes, there is also a rising concern about its associated complications, such as peripheral neuropathy. The diabetic control activities in Kottayam are functioning effectively through NCD clinics that offer comprehensive care, including regular screening, treatment, lifestyle counselling, and follow up services, contributing to better control and prevention of diabetes in the community. Even though several clinical assessment methods are available to find DPN at the community level, only a few studies have been conducted in Kerala to determine the prevalence of DPN. In this paucity, this study aimed to screen diabetics aged 30 yr and above in the Ettumanoor municipality for DPN. Furthermore, the association between the selected factors, including socio-demographic factors, duration of diabetes, glycaemic control, other co-morbidities like hypertension, obesity, dyslipidaemia, and habits like smoking and alcohol consumption, was also explored.

Materials & Methods

A cross-sectional study was conducted in individuals aged 30 and above of both genders diagnosed with Type 2 Diabetes mellitus for at least one year and residing at the Ettumanoor municipality. The study was conducted from September 2020 to April 2021, over a period of eight months at the department of Community Medicine, Government Medical College (GMC), Kottayam, Kerala, India after obtaining approval from the Institutional Review Board of GMC, Kottayam, Kerala. Written informed consent was obtained for participation in the study and use of the patient data for research and educational purposes. The procedures in the study follow the guidelines laid down in the Declaration of Helsinki.

Consenting individuals aged 30 yr and above, of both genders, diagnosed with type 2 diabetes mellitus for at least one year were included in the study. Individuals with type 1 diabetes mellitus, gestational diabetes, past history of cerebrovascular accident, end-stage renal disease, hypothyroidism, peripheral occlusive vascular disease, and history of major spinal trauma or surgery were excluded from the study. Exclusion was done by verifying hospital records.

According to a study done at Chittoor, Andhra Pradesh, the prevalence of diabetic peripheral neuropathy (DPN) was estimated to be 39.3 per cent5. The sample size was estimated after taking the prevalence of above-mentioned study, and using the formula, Z2 PQ/d2. Relative precision taken here is 15 per cent of prevalence, thus the sample size obtained was 263. As cluster sampling was planned, after giving a design effect of 2, the minimum sample size was 263 x 2 =526.

Ettumanoor Municipality, with a total area of 24.78 square km according to the 2011 census, comes under Kottayam district, in the State of Kerala, and covers a population of 51,129. It consists of 35 wards, and the study participants were selected from all the wards. The number of persons chosen from each ward was 15 (526/35), and the houses were selected from each ward, by the following method.

A location near the centre of the ward was selected. A random direction, defined by spinning a bottle and choosing the direction that the bottle neck points to, was taken, and a random household, along the chosen direction pointing outwards from the centre of the community to its boundary, was chosen. The nearest household to the first one was chosen next and then houses were taken one after the other till the required sample in that cluster was met. Only one individual with diabetes was selected from each household.

A total of 543 individuals were approached for participation in the study. However, 17 declined to participate, and they were subsequently excluded from the study. A semi-structured interview schedule was administered to all the study participants, containing information on sociodemographic data, BMI, disease-related factors, treatment-related factors, and factors related to footcare. Modified Kuppuswamy classification was used to assess the socioeconomic status8. BMI is based on Asian classification, where underweight is <18.5, 18.5-22.9 is normal, 23-24.9 is overweight, and >/=25 is considered obese9. Smoking was measured in pack years. Current smokers were those who reported to smoke at least 100 cigarettes in their lifetime and who, at the time of the survey, used tobacco for smoking. Ex-smokers were those who reported to smoke at least 100 cigarettes in their lifetime and who, at the time of the survey, did not smoke at all. Never smokers were respondents who never smoked 100 cigarettes in their lifetime. A person who never consumed alcohol in their lifetime was considered anon-alcoholic, and occasional if they consumed alcohol 1-2 times/month, often if taken 1-2 times/wk, and very often >/=3 times/wk.

Treatment-related factors included irregular intake of medicines and self-modification of medicines. Participants who failed to take regular medications as prescribed more than half of the time over the last month were considered as on irregular medication. Those who altered their medications during the last month, like adjusting insulin doses, were considered to have done self-modification of medication. Fasting blood sugar (FBS) and postprandial blood sugar (PPBS) laboratory values recorded within the past two months were taken. Those with FBS values in the range of 80-130 mg/dl and PPBS <180 mg/dl were considered as controlled10.The presence of diabetes related complications like retinopathy and nephropathy was confirmed based on hospital records. DPN was screened using a previously validated tool, the Michigan neuropathy screening instrument (MNSI)11. MNSI is a screening tool for DPN, developed and validated by the University of Michigan. Interview questions were translated into the local language and were administered by the principal investigator. Examination was also performed simultaneously at the participants’ houses by the principal investigator, who was trained in performing ankle reflex, assessing vibration sense using a tuning fork, and evaluating protective sensation using a monofilament.

MNSI has a sensitivity of 80 per cent and specificity of 95 per cent, and had two components, the history and the physical assessment component. The first part of the screening instrument consisted of 15 self-administered ‘yes or no’ questions on foot sensation, including pain, numbness, and temperature sensitivity. A score of 4 or above indicates neuropathic symptoms. The second part of the MNSI is a brief physical examination involving inspection of the feet for deformities and ulceration, assessment of vibration sensation at the great toe, grading of ankle reflexes, and monofilament testing. Patients screening positive on the clinical portion of the MNSI (greater than 2.5 points on a 10-point scale) are considered neuropathic12.

The test of vibration was performed bilaterally using a 128 Hz tuning fork placed over the dorsum of the great toe on the distal interphalangeal joint. Zero score indicates intact vibration sensation; the examiner senses the vibration on his/her finger for <10 sec longer than the subject feels it over the great toe. Reduced sensation was scored as 0.5 if the examiner sensed vibration for 10 sec or more, and the lack of vibration sensation was scored as 1. Ankle reflex was assessed using a percussion hammer. If the reflex was absent, the Jendrassic manoeuvre was performed. Reflexes elicited without reinforcement were scored as zero, those with reinforcement scored as 0.5, and if absent scored as one. To assess protective sensation, a 10 g monofilament was placed perpendicular to the skin and pressure applied until the filament just buckled with a contact time of two seconds. The 10 g monofilament was applied over ten points on each foot; a ‘yes’ response indicated filament sensation. Eight correct responses out of 10 applications were considered as normal, 1-7 correct responses as reduced sensation, and no correct answer as absent sensation12.

Statistical analysis

Data was properly coded and entered in Microsoft Excel and analysed using IBM SPSS software version 20 (IBM Copr., TX, USA). The main outcome variable, the prevalence of peripheral neuropathy and sociodemographic profile (gender, age group, occupation, education, and socioeconomic status), is expressed as percentage. Association of peripheral neuropathy with various qualitative variables was assessed using chi-square test. The level of significance was fixed at a P< 0.05. The factors that were found to have a significant relationship with DPN were analysed using logistic regression.

Results

This cross-sectional study was conducted among 526 individuals of Ettumanoor Municipality in Kottayam district. Study participants were selected from all 35 wards of Ettumanoor municipality with an equal number of subjects from each ward. The baseline socio-demographic variables (Table I).

Table I. Distribution of study participants based on other sociodemographic factors
Variables Parameters Frequency Percentage (%)
Age group (yr) 30-49 31 5.9
50-59 144 27.4
>60 351 66.7
Gender Male 177 33.65
Female 349 66.35
Education Illiterate 14 2.7
School 431 81.9
Intermediate or diploma 58 11.0
Graduate 20 3.8
Profession/ honours 3 0.6
Occupation Unemployed 328 62.4
Employed 198 37.6
Socio economic status Upper 10 1.9
Upper middle 17 3.2
Lower middle 114 21.7
Upper lower 326 62
Lower 59 11.2
Type of family Nuclear 288 54.8
Joint 14 2.7
Three generation 224 42.5
Marital status Married 390 74
Widow/widower 132 25
Unmarried 4 1

The mean age of the study participants’ was 62.72 yr, with a standard deviation of 9.01 yr, and the age range was between 35 and 98 yr. The majority were females (66.3%) and belonged to the upper-lower socioeconomic status, according to the modified Kuppuswamy Scale13. In the study population, 402 individuals (76.4%) were diagnosed with hypertension, 276 (52.4%) had dyslipidaemia, 83 (15.7%) had coronary artery disease, 34 (6.46%) had osteoarthritis, 28 (5.32%) had asthma, 7 (1.3%) had COPD, and 11 (2%) had carcinomas

In the current study median duration of diabetes among the study participants is seven yr with an interquartile range of 10 yr. The prevalence of DPN among diabetic individuals aged 30 yr and above in Ettumanoor municipality, as per MNSI Examination score, was found to be 34.2 per cent (95% C.I.: 30.2-38.4) (Fig. 1).

Distribution of the study participants (N=526) based on prevalence of diabetic peripheral neuropathy (DPN) using MNSI Examination score.
Fig. 1.
Distribution of the study participants (N=526) based on prevalence of diabetic peripheral neuropathy (DPN) using MNSI Examination score.

Age, education, occupation, duration of diabetes, height more than 160 cm, use of insulin, irregular medication, and presence of hypertension, retinopathy, and nephropathy were found to have a significant association with DPN on univariate analysis (Table II). Gender, socioeconomic status, BMI, habits like smoking and alcohol consumption, FBS, PPBS, and barefoot walking did not have any significant association with DPN.

Table II. Summary of table showing variables statistically significant with DPN on univariate analysis in study subjects
Variable Category (with highest %) Chi square P value
Duration of diabetes ≥ 10 yr (42.1) 10.46 0.001
Age group ≥ 60 yr (38.5) 8.43 0.004
Education High school & below (38.7) 25.20 < 0.001
Occupation Unemployed (39.8) 11.76 0.001
Height ≥ 160 cm (41.5) 6.66 0.010
Type of medication On insulin use (53.2) 29.31 < 0.001
Regular medication Irregular (45.7) 6.47 0.011
Self-modification of medication for diabetes Yes (55.4) 19.67 0.03
Hypertension Present (37.6) 8.45 0.004
Retinopathy Present (50.8) 8.44 0.004
Nephropathy Present (87.5) - 0.003

Those variables that were found to have a significant association with DPN with P<0.05 in univariate analysis were further analysed using binary logistic regression (Table III). The method of logistic regression used was the Enter method. Model summary as explained by the Negelkerke R2 value obtained in the final model was 0.31. According to this model, the factors which were found to be independent predictors (with P<0.05) of DPN were individuals aged >60 yr [adjusted OR-1.88 (1.10-3.21)], educational status, high school and below [adjusted OR- 1.26 (1.12-1.43)], unemployment adjusted [OR-1.79 (1.08-2.97)], height >160 cm [adjusted OR-1.86 (1.15-3)] and insulin use [adjusted OR-1.45 (1.08- 1.94)].

Table III. Logistic regression of variables which showed significant association with DPN
Variables Unadjusted odds ratio Adjusted odds ratio P value 95% confidence interval
Lower Upper
Duration of diabetes 1.82 1.077 0.744 0.688 1.687
Age group (≥ 60 yr) 1.80 1.886 0.020 1.106 3.217
Education (high school and below) 5.75 1.269 0.000 1.120 1.439
Occupation (unemployed) 1.96 1.797 0.022 1.0877 2.971
Height (≥160 cm) 1.63 1.861 0.011 1.152 3.006
Type of medication (on insulin) 2.97 1.453 0.012 1.087 1.944
Irregular medication 1.80 1.217 0.601 0.583 2.540
Self modification of medication 2.87 2.008 0.083 0.913 4.415
Hypertension (present) 1.97 1.211 0.489 0.703 2.087
Retinopathy (present) 2.19 1.759 0.090 0.916 3.377
Nephropathy (present) 13.96 11.550 0.031 1.249 106.777

Discussion

Among the 526 study subjects, an increased prevalence of DPN was observed in the age group of > 60 yr (66.7%) who were either retired or had stopped working. In most houses, the working population was not available during data collection time. Furthermore, because diabetes prevalence is thought to rise with age, most of the participants as expected in this study were elderly.

Socioeconomic status classification was done with Modified Kuppuswamy classification (Reference to CPI-March 2021), and a majority of the current study population belonged to the upper -lower class, possibly due to the change in Consumer Price Index (CPI) in March 2021 when compared to previous years.

In the current study, the prevalence of DPN among individuals aged ≥30 yr was found to be 34.2 per cent (95% CI- 30.2-38.4). Similar results were found in a study conducted by Darivemula et al5 in rural South India, where the prevalence of DPN was found to be 39.3 per cent. A community-based study to estimate the prevalence and associated factors of diabetes [Chennai Urban Rural Epidemiology Study (CURES-55)] found that DPN prevalence was 26.1 per cent14. Another study done at Uttar Pradesh by Gill et al15 showed a prevalence of 29.2 per cent.

Higher prevalence was obtained in other studies done in Kerala by George et al16, in which the prevalence of DPN was 47 per cent, and by Sankar et al17, where the prevalence was 45.8 per cent. A study done in South India by Jasmine et al18, the prevalence was 44.9 per cent, and another study conducted at North India by Bhasker et al19, the estimated prevalence of DPN was 42 per cent. A much lower prevalence was obtained in a study conducted by Ashok et al20 in South India, where it was 19.1 per cent. The prevalence of DPN across 14 countries in the INTERPRET-DD Study was 26.71 per cent6. These differences in the prevalence may be due to the difference in study settings and socio-demographic features, and the difference in the screening tool used. Most of the studies were hospital or clinic-based, only a few studies were community-based.

In this study, it was found that as age increased, there was a significant increase in the prevalence of DPN (P value=0.015). Similar results were obtained in other studies5,7,14,21, where there was an increasing trend of DPN in older individuals. This may be due to biological changes leading to increased production of advanced glycosylation end-products (AGEs), defect in the polyol pathway, nerve vascular alterations, and impaired resistance to oxidative stress.

In the current study, there was no significant association between gender and DPN. Similar results were obtained in a community study (CURES-55)14 and a study done in Kerala22, where there were no gender specific differences. People having a high school education or below had a higher proportion of DPN (38.7%) (P< 0.001). Similar results were obtained in studies done by Kamalarathnam et al7 and Jasmine et al18. DPN was observed to be higher in unemployed (39.8%) when compared to employed (25.1%) a with a P< 0.001 in this present study similar to Kamalarathnam et al7 and Mathiyalagen et al22. For those participants with a duration of diabetes of more than 10 yr, a significant association was present (P=0.001). In a study done by Darivemula et al5 there was a significant association between the duration of diabetes of > 5 yr and DPN [(52.6% OR = 0.23 (0.13-0.39)P=0.01]. Similar results were obtained in the multicentric study, INTERPRET-DD6.

There was a significant association between increased height (above 160 cm) and DPN (P=0.01). Similar results were shown by other studies by Robinson et al2, where peripheral neuropathy risk was significantly higher among those taller than 175.5 cm [(odds ratio=2.3,(95% CI: 1.5-3.5)] and Sankar et al21. In another study from Manipal24, peripheral neuropathy increased at a height of more than 167 cm in males and at a height of > 159 cm in females.

About 53.2 per cent of participants on insulin therapy had DPN with a P<0.001 similar to earlier observations21,25,26 (OR: 4.50; CI: 1.50-13.47). Hypertension was associated with DPN in the current study (P=0.004). Similar to other studies5,26. The evidence from the UK Prospective Diabetes Study (UKPDS) also demonstrated that improvement in blood pressure reduced diabetes related complications27. In the current study, smoking and alcohol had no significant association with DPN, while the presence of other microvascular complications (retinopathy and nephropathy) had a significant association similar to previous reports4,5.

The strength of this study was that as it is a community-based study and the sampling used was probability sampling, generalisability was possible. But, as this was a cross-sectional study, the temporal association of factors with DPN could not be established. Also, there can be other causes of peripheral neuropathy among diabetics-like vitamin B12 deficiency, vitamin B1 deficiency, autoimmune neuropathies, and uremic neuropathy, which couldn’t be differentiated. Some of the variables in the study, like smoking, consumption of alcohol, treatment related factors, and footcare practices, were self-reported, with a chance of recall bias. The representation of the working group was lower in the current study. Also, as the study focused on subjective assessment of neuropathy, there is a chance for observer bias, MNSI examination part was done initially to overcome this.

Overall, the prevalence of DPN was found to be high in the study population. Factors which were found to be independent predictors of DPN include age > 60 yr, below high school education, unemployed status, height more than 160 cm, Insulin use and presence of nephropathy. The association of diabetes duration, irregular medication, self-modification of medications, presence of hypertension, and retinopathy with DPN was no longer significant after adjusting for confounders. All diabetics in the community should undergo screening for microvascular complications, including DPN, starting at diagnosis and annually thereafter. Early community-based diagnosis using screening tools such as MNSI will aid in instituting appropriate interventions to halt the progression of these complications. In cases where neuropathy was detected, participants were advised to seek further evaluation and management at the nearest health centre. Additionally, they were provided with individual health education on proper foot care practices.

Acknowledgment

Authors acknowledge all the field staff for their assistance.

Financial support & sponsorship

None.

Conflicts of Interest

None.

Use of Artificial Intelligence (AI)-Assisted Technology for manuscript preparation

The authors confirm that there was no use of AI-assisted technology for assisting in the writing of the manuscript and no images were manipulated using AI.

References

  1. , , , , , , et al. Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17) Lancet Diabetes Endocrinol. 2023;11:474-89.
    [Google Scholar]
  2. . Foot Complications. Available from: https://diabetes.org/about-diabetes/complications/foot-complications, accessed on April 16, 2025.
  3. , , . Treating painful diabetic peripheral neuropathy: an update. Am Fam Physician. 2016;94:227-34.
    [Google Scholar]
  4. , , , , , . Prevalence and risk factors of development of peripheral diabetic neuropathy in type 2 diabetes mellitus in a tertiary care setting. J Diabetes Investig. 2014;5:714-21.
    [Google Scholar]
  5. , , , , , . Prevalence and its associated determinants of diabetic peripheral neuropathy (DPN) in individuals having type-2 diabetes mellitus in rural South India. Indian J Community Med. 2019;44:88-91.
    [Google Scholar]
  6. , , , , , , et al. The INTERPRET-DD study of diabetes and depression: a protocol. Diabet Med. 2015;32:925-34.
    [Google Scholar]
  7. , . Diabetic peripheral neuropathy in diabetic patients attending an urban health and training centre. J Family Med Prim Care. 2022;11:113-7.
    [Google Scholar]
  8. . Socioeconomic status scales: Revised Kuppuswamy, BG Prasad, and Udai Pareekh’s scale updated for 2021. J Family Med Prim Care. 2021;10:3964-7.
    [Google Scholar]
  9. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-63.
    [Google Scholar]
  10. Glycemic Targets: Standards of Medical Care in Diabetes 2022. Diabetes Care. American Diabetes Association, Arlington, Virginia. American Diabetes Association : S62-69.
  11. , , , , , , et al. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med. 2012;29:937-44.
    [Google Scholar]
  12. Herman WH. MNSI_patient.pdf. NIDDK Central Repository. Available from: https://repository.niddk.nih.gov/media/studies/search/MOPs/SEARCH%201-3%20MOP/SEARCH(16).pdf, accessed on February 7, 2025.
  13. . Socioeconomic status scales-modified Kuppuswamy and Udai Pareekh’s scale updated for 2019. J Family Med Prim Care. 2019;8:1846-9.
    [Google Scholar]
  14. , , , , , , et al. The Chennai Urban Rural Epidemiology Study (CURES)-study design and methodology (urban component) (CURES-I) J Assoc Physicians India. 2003;51:863-70.
    [Google Scholar]
  15. , , , . Prospective study of prevalence and association of peripheral neuropathy in Indian patients with newly diagnosed type 2 diabetes mellitus. J Postgrad Med. 2014;60:270-5.
    [Google Scholar]
  16. , , , , , , et al. Foot care knowledge and practices and the prevalence of peripheral neuropathy among people with diabetes attending a secondary care rural hospital in Southern India. J Family Med Prim Care. 2013;2:27-32.
    [Google Scholar]
  17. , . A study on prevalence of diabetic peripheral neuropathy in diabetic patients attending a rural health and training centre. J Family Med Prim Care. 2024;13:726-9.
    [Google Scholar]
  18. , , , , , , et al. Prevalence of peripheral neuropathy among type 2 diabetes mellitus patients in a rural health centre in South India. Int J Diabetes Dev Ctries. 2020;41:293-300.
    [Google Scholar]
  19. , . Prevalence and determinants of diabetic peripheral neuropathy/foot syndrome in the rural population of North India. Iberam J Med. 2021;3:18-25.
    [Google Scholar]
  20. , , , . Prevalence of neuropathy in type 2 diabetic patients attending a diabetes centre in South India. J Assoc Physicians India. 2002;50:546-50.
    [Google Scholar]
  21. , . High prevalence of peripheral neuropathy in type 2 diabetes: a hospital-based cross-sectional study from South India. International Diabetes Federation 2017 2017
    [Google Scholar]
  22. , , , , . Prevalence and determinants of peripheral neuropathy among adult type II diabetes mellitus patients attending a non-communicable disease clinic in rural South India. Cureus. 2021;13:e15493.
    [Google Scholar]
  23. , , , , , . Height is an independent risk factor for neuropathy in diabetic men. Diabetes Res Clin Pract. 1992;16:97-102.
    [Google Scholar]
  24. , , , , . Peripheral insensate neuropathy—is height a risk factor? J Clin Diagn Res. 2013;7:296-301.
    [Google Scholar]
  25. , , , , . Community-based study to assess the prevalence of diabetic foot syndrome and associated risk factors among people with diabetes mellitus. BMC Endocr Disord. 2018;18:43.
    [Google Scholar]
  26. , , , , . Prevalence and risk factors of diabetic peripheral neuropathy among type-2 diabetic patients presenting to SMIMS hospital, Kulasekharam, Kanyakumari district, Tamil Nadu, India. Int J Med Sci Public Health. 2013;2:73.
    [Google Scholar]
  27. , , . The UK Prospective Diabetes Study (UKPDS): clinical and therapeutic implications for type 2 diabetes. Br J Clin Pharmacol. 1999;48:643-8.
    [Google Scholar]
Show Sections
Scroll to Top